Skip to main content

Option Care Health Value Stock - Dividend - Research Selection

Bioscrip

ISIN: US68404L2016 , WKN: A2PZEY

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

BioScrip, Inc. provides infusion solutions in the United States. It engages in the preparation, delivery, administration, and clinical monitoring of pharmaceutical treatments that are administered to a patient through intravenous, subcutaneous, intramuscular, intra-spinal, and enteral methods. The company is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic disorders, cancer, pain, and palliative care. It also offers home nursing products and services to patients suffering from chronic and acute medical conditions. The company offers its services at patient\'s homes, outpatient clinics, nursing facilities, physician\'s offices, and ambulatory infusion centers. It markets and sells its products and services through sales and marketing representatives, and payor relationships. The company was founded in 1993 and is based in Denver, Colorado.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


BTSG Gains More Than 54% YTD: Should You Buy, Hold or Sell?

2026-09-11
BrightSpring Health Services has surged 54% YTD on specialty pharmacy, infusion and EBITDA growth, but premium valuation and policy headwinds remain.

2 Small-Cap Stocks with Promising Prospects and 1 We Brush Off

2026-09-10
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.

Should Value Investors Buy Option Care Health (OPCH) Stock?

2026-09-07
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Can BTSG Outgrow the $20B Acute Infusion Market on Volume Growth?

2026-09-04
BrightSpring Health Services is gaining acute infusion share with 20%+ volume growth, targeting 12-15 new states in a $20 billion market.

Senior Health, Home Health & Hospice Stocks Q2 Results: Benchmarking Option Care Health (NASDAQ:OPCH)

2026-09-03
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the senior health, home health & hospice stocks, including Option Care Health (NASDAQ:OPCH) and its peers.

Option Care Health to Participate in Upcoming Investor Conferences

2026-09-02
BANNOCKBURN, Ill., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced that John Rademacher, CEO and Meenal Sethna, CFO, will participate in the following up coming investor conferences: Morgan Stanley 24th Annual Global Healthcare Conference, being held in New York City, on Tuesday, September 15, 2026 at 10:45am ET/9:45am CT.Deutsche Bank 2026 Healthca

Option Care Health (OPCH) Stock Looks Fully Priced On Cash Flow But Cheap On Earnings

2026-09-01
Option Care Health stock has had a difficult few years, yet the current valuation checks do not all point in the same direction. The intrinsic value estimate using a Discounted Cash Flow model suggests the shares trade at a premium to that model, while market based multiples look more supportive. Over the past 3 years the share price has declined 32.2%, which puts extra focus on whether the current level already reflects the weaker shareholder returns. Future profitability and cash flow from...

Zacks Industry Outlook Highlights DaVita, LifeStance Health, Option Care Health, and Aveanna Healthcare

2026-08-31
Outpatient and home healthcare stocks gain from aging, digital care and AI, with LifeStance, Option Care, Aveanna and DaVita in focus.

4 Outpatient & Home Healthcare Stocks in Focus Amid Industry Tailwinds

2026-08-28
An aging population and growing telehealth and AI adoption support the Zacks Medical - Outpatient and Home Healthcare industry. DVA, LFST, OPCH and AVAH stand to benefit.

1 Cash-Producing Stock for Long-Term Investors and 2 We Ignore

2026-08-27
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.